A peptide vendor got a letter from FDA last month listing the evidence against them. Website copy. Product descriptions. Clinical percentages quoted in the marketing.
And bacteriostatic water, sold next to a peptide guide and a dosing calculator.
Read that last part again. The bac water is evidence. FDA wrote that selling it alongside a guide and a calculator provides "the means to prepare an injectable drug for human administration." Three products that are each legal on their own, sitting on the same site, and FDA says the combination tells them what you meant.
Every store you buy from does this. So does mine.
What actually happened
Five vendors got warning letters dated August 24. FDA posted them September 1. Royal Peptides, NuScience Peptides, Peptide Partners, TXP Innovations and Peak Performance Peptides.
The compounds named run well past the weight loss menu. Tirzepatide, semaglutide and retatrutide, sure. Also SS-31, PT-141, tesamorelin and bimorelin. If you were telling yourself this is a GLP problem and your BPC or your PT-141 sits in a different category, the letters say otherwise.
Fifteen business days to respond. The letters say failure to fix it can lead to seizure or injunction without further notice. Those fifteen days ran out around the middle of September, which means whatever happens next is happening now.
The disclaimer was never doing what you think it was doing
Here is the part most people have backwards.
Everyone treats "research use only, not for human consumption" like a password. Say the words, the rules do not apply. Buyers assume it is a legal shield and vendors assume it is a legal shield, and both groups have watched it work for years, so the assumption hardens.
FDA does not read labels that way and never has. They use something called a net impression standard, which means they read your entire site and decide what a normal person would conclude you were selling. The disclaimer is one input. The product description is another. What you bundle with it is another. Add them up and that is your intent, whatever the fine print says.
The ArentFox Schiff lawyers who broke down these letters put it plainly. The research label cannot substitute for drug approval, compliant manufacturing, or evidence that a vial is safe to inject.
So the shield was never real. It just had not been tested in writing against this many vendors at once.
The seven things FDA actually pointed at
Pulled straight from the letters and the legal breakdown. This is the list, in the order it shows up.
Product descriptions that frame the compound therapeutically. One cited line was that tirzepatide "has become a major focus of metabolic, endocrinology, obesity, and peptide science." Sounds like a neutral fact. FDA read it as a claim about what the product is for.
Clinical percentages in the marketing. Quoting "up to 22.5% body weight reduction" on a product page ties trial results to the vial you are selling.
Bacteriostatic water sold alongside. On its own it is a sterile diluent. Next to peptides it is half of an injection kit.
Reconstitution calculators. A tool whose only purpose is working out how to mix something for injection.
Peptide guides. Same logic. Nobody needs a preparation guide for a compound that stays in a freezer.
Dosing guidance of any kind. Milligrams, schedules, protocols, anything that tells a person how much.
Disease claims. The obvious one, and the one most stores already avoid.
Notice how few of those are the store being reckless. Items three through six are the store being helpful. That is what makes this different from the usual enforcement story. The stuff that got flagged is the stuff that made those sites useful.
What the stores do next
This is my read, and I will label it as a read. Nobody has announced anything.
Every competent operator in this space read those letters within about a week, and the cheapest way to get off the list is to strip the flagged features. So expect calculators to disappear. Expect bac water to get unbundled or dropped entirely. Expect product pages to get shorter and vaguer, with the research framing pulled out and nothing put in its place. Expect the guides to come down.
None of that changes what is in the vial. It changes how much you can find out before you buy one.
The stores are about to get quieter and dumber, and they are doing it on purpose, because the helpful version is the version that draws a letter. A vendor who keeps the calculator up is a vendor who has decided the fifteen days do not apply to them. That is a bet, and it is worth knowing which vendors are making it.
What this means for you
Four days ago I wrote that supply is getting tight because the pipe narrowed in December and the October holiday is about to land on top of it. This is the same squeeze from the other end. The supply got harder to get and now the information is getting harder to find.
So the practical version. Save anything you rely on before it comes down, because a calculator or a guide you use today may not be there in November. Judge a store on what it ships rather than on how informative the site is, since the informative ones are about to become the cautious ones and that says nothing about the product. And stop reading the disclaimer as a signal of anything, because it was never a signal, it was a habit.
The education layer is moving off the storefronts. It has to live somewhere.
That somewhere is the Discord. It is free, it is where this conversation is already happening, and it does not have a compliance department deciding what it is allowed to explain to you.
P.S. Do not take my summary for it. The Royal Peptides letter is public and it is four pages. Read the footnote where they explain the bac water. It is the clearest thing FDA has written about this market in a year.
P.P.S. If you asked for a brand audit and have not gotten yours yet, that one is on me. We got a lot more interest than we planned for and they are taking longer than I said they would. A few have already gone out, so check your DMs from @biohackernetwork before you assume yours got lost.
If you never sent your domain over, the audit list is closed for now. Reply AUDIT and I will put you on the list for the next round.